North Star Investment Management Corp. Gilead Sciences, Inc. Transaction History
North Star Investment Management Corp.
- $1.42 Billion
- Q4 2024
A detailed history of North Star Investment Management Corp. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, North Star Investment Management Corp. holds 226 shares of GILD stock, worth $21,578. This represents 0.0% of its overall portfolio holdings.
Number of Shares
226
Previous 395
42.78%
Holding current value
$21,578
Previous $33,000
39.39%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding GILD
# of Institutions
1,993Shares Held
993MCall Options Held
10.1MPut Options Held
8.85M-
Black Rock Inc. New York, NY121MShares$11.5 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$11 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$7.31 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$5.9 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.75 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $120B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...